Reported Earlier, Zentalis Pharmaceuticals Prices Underwritten Public Offering Of 23M Shares At $3.50 Per Share, Expects $80.5M Gross Proceeds

Loading news article.

Reported Earlier, Zentalis Pharmaceuticals Prices Underwritten Public Offering Of 23M Shares At $3.50 Per Share, Expects $80.5M Gross Proceeds | WAPE

Article summary